Earnings Scheduled For June 7, 2016

By: via Benzinga
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is estimated to report its quarterly earnings at $1.37 per share on revenue of $2.38 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.